India, Feb. 17 -- Sartorius AG (SARTF), a German pharmaceutical and lab equipment company, reported that its net profit attributable to equity holders for fiscal year 2024 dropped to 84.0 million euros or 1.21 euros per ordinary share from last year's 205.6 million euros or 3.00 euros per ordinary share.
Earnings before interest and taxes (EBIT) declined to 392.6 million euros from 504.6 million euros in the prior year, reflecting the higher amortization resulting from the full-year consolidation of Polyplus as well as the increase in extraordinary items. This increase resulted primarily from expenses for efficiency measures, which overlapped with the associated savings in the reporting year, as well as from expenses for various corporate ...